[go: up one dir, main page]

UY30322A1 - Moduladores bencimidazólicos de vr1 - Google Patents

Moduladores bencimidazólicos de vr1

Info

Publication number
UY30322A1
UY30322A1 UY30322A UY30322A UY30322A1 UY 30322 A1 UY30322 A1 UY 30322A1 UY 30322 A UY30322 A UY 30322A UY 30322 A UY30322 A UY 30322A UY 30322 A1 UY30322 A1 UY 30322A1
Authority
UY
Uruguay
Prior art keywords
bencimidazolic
modulators
compounds
formula
treatment
Prior art date
Application number
UY30322A
Other languages
English (en)
Inventor
Derek A Beauchamp
Kenneth M Wells
Wenxi Pan
Yu-Kai Lee
Wing S Cheung
Jian Liu
Sharmila Patel
Michael Brandt
Mark A Youngman
Mark A Player
William Parsons
Michele C Jetter
Scott L Dax
Raul R Calvo
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of UY30322A1 publication Critical patent/UY30322A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La invención se refiere a compuestos de Fórmula (I): a composiciones farmacéuticas que contienen tales compuestos y a métodos de tratamiento para utilizarlos.
UY30322A 2006-05-03 2007-05-03 Moduladores bencimidazólicos de vr1 UY30322A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79750406P 2006-05-03 2006-05-03

Publications (1)

Publication Number Publication Date
UY30322A1 true UY30322A1 (es) 2007-08-31

Family

ID=38566108

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30322A UY30322A1 (es) 2006-05-03 2007-05-03 Moduladores bencimidazólicos de vr1

Country Status (36)

Country Link
US (3) US7951829B2 (es)
EP (1) EP2021330B1 (es)
JP (1) JP5302884B2 (es)
KR (1) KR101434883B1 (es)
CN (1) CN101511797B (es)
AR (1) AR060840A1 (es)
AT (1) ATE482201T1 (es)
AU (1) AU2007248341C1 (es)
BR (1) BRPI0709803B8 (es)
CA (1) CA2651128C (es)
CO (1) CO6160329A2 (es)
CR (1) CR10479A (es)
CY (1) CY1111269T1 (es)
DE (1) DE602007009378D1 (es)
DK (1) DK2021330T3 (es)
EA (1) EA019386B1 (es)
EC (1) ECSP088854A (es)
ES (1) ES2350959T3 (es)
HR (1) HRP20100700T1 (es)
IL (1) IL194916A (es)
JO (1) JO3602B1 (es)
MX (1) MX2008014108A (es)
MY (1) MY154595A (es)
NI (1) NI200800290A (es)
NO (1) NO341965B1 (es)
NZ (1) NZ572251A (es)
PE (1) PE20080065A1 (es)
PL (1) PL2021330T3 (es)
PT (1) PT2021330E (es)
RS (1) RS51473B (es)
SI (1) SI2021330T1 (es)
TW (1) TWI419882B (es)
UA (1) UA94749C2 (es)
UY (1) UY30322A1 (es)
WO (1) WO2007130780A2 (es)
ZA (1) ZA200810234B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0721169A2 (pt) * 2006-12-15 2014-03-18 Janssen Pharmaceutica Nv Inibidores de benzimidazol trpv1
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
WO2009079000A1 (en) * 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolopyrimidine modulators of trpv1
WO2009078999A1 (en) 2007-12-17 2009-06-25 Janssen Pharmaceutica N.V. Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1
US8362012B2 (en) * 2008-04-18 2013-01-29 Daewoong Pharmaceutical Co., Ltd. Benzoxazine benzimidazole derivative, a pharmaceutical composition comprising the same, and a use thereof
US8232409B2 (en) 2008-10-15 2012-07-31 Janssen Pharmaceutica N.V. Heterocyclic benzimidazoles as TRPM8 modulators
US8217060B2 (en) * 2009-05-15 2012-07-10 Janssen Pharmaceutica, Nv Benzimidazole derivatives useful as TRP M8 receptor modulators
US8323805B2 (en) * 2009-06-04 2012-12-04 Nitto Denko Corporation Emissive aryl-heteroaryl acetylenes
CN102002010A (zh) * 2009-08-31 2011-04-06 住友化学株式会社 双噁唑啉基烷烃化合物的精制方法
AU2012255935B2 (en) 2011-05-16 2016-06-23 Innovation Pharmaceuticals Inc. Compounds for use in treatment of mucositis
US9056874B2 (en) 2012-05-04 2015-06-16 Novartis Ag Complement pathway modulators and uses thereof
CN105229003B (zh) 2013-03-14 2017-03-15 诺华股份有限公司 作为补体因子b抑制剂用于治疗眼科疾病的2‑(1h‑吲哚‑4‑基甲基)‑3h‑咪唑并[4,5‑b]吡啶‑6‑甲腈衍生物
MX366875B (es) 2013-07-11 2019-07-29 Bristol Myers Squibb Co Inhibidores de indoleamina 2,3-dioxigenasa (ido).
EP3089963A1 (en) 2013-10-30 2016-11-09 Novartis AG 2-benzyl-benzimidazole complement factor b inhibitors and uses thereof
EP3348554B1 (en) * 2015-09-08 2020-05-06 Sumitomo Chemical Company, Limited Method for producing triazole compound
CA3041332A1 (en) * 2016-11-01 2018-05-11 Merck Sharp & Dohme Corp. Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptors
AU2019262169B2 (en) * 2018-05-03 2024-05-02 Jiangsu Hengrui Medicine Co., Ltd. Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORy) and pharmaceutical uses thereof
CN108997398B (zh) * 2018-07-23 2020-12-15 被忽略疾病药物研发组织 一种3,3-二甲基苯并[c][1,2]氧杂戊硼烷-1(3h)-醇的制备方法
CN112745268B (zh) * 2019-10-31 2022-09-16 江苏恒瑞医药股份有限公司 苯并咪唑衍生物的晶型及制备方法
AU2020377114A1 (en) * 2019-10-31 2022-06-16 Jiangsu Hengrui Medicine Co., Ltd. Acid addition salt of RORγ regulator
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
US6299796B1 (en) 1997-12-18 2001-10-09 Fuji Photo Film Co., Ltd. Styryl compound, method for the preparation thereof and electroluminescent element employing the same
US6748803B1 (en) * 2000-02-22 2004-06-15 Simmonds Precison Products, Inc. Liquid measurement system and shared interface apparatus for use therein
WO2004035549A1 (en) * 2002-10-17 2004-04-29 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
US7135493B2 (en) * 2003-01-13 2006-11-14 Astellas Pharma Inc. HDAC inhibitor
HRP20060041B1 (hr) * 2003-07-28 2014-06-06 Janssen Pharmaceutica N.V. Derivati benzoimidazola, benzotiazola i benzooksazola i njihova uporaba kao modulatora lta4h
US7309716B2 (en) * 2003-10-28 2007-12-18 Vertex Pharmaceuticals Incorporated Benzimidazoles useful as modulators of ion channels
WO2006058338A2 (en) * 2004-11-29 2006-06-01 Janssen Pharmaceutica N.V. 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor
PL2081572T3 (pl) * 2006-07-04 2010-07-30 Janssen Pharmaceutica Nv Benzimidazolowe związki antagonistyczne wobec receptora kannabinoidowego zawierające podstawioną grupę heterocykliczną
BRPI0721169A2 (pt) * 2006-12-15 2014-03-18 Janssen Pharmaceutica Nv Inibidores de benzimidazol trpv1

Also Published As

Publication number Publication date
IL194916A0 (en) 2009-08-03
JO3602B1 (ar) 2020-07-05
BRPI0709803B1 (pt) 2019-12-10
CA2651128A1 (en) 2007-11-15
CR10479A (es) 2009-03-31
NO20085031L (no) 2009-01-06
CO6160329A2 (es) 2010-05-20
US20110190344A1 (en) 2011-08-04
US7951829B2 (en) 2011-05-31
ECSP088854A (es) 2008-11-27
ES2350959T3 (es) 2011-01-28
MX2008014108A (es) 2008-11-14
NZ572251A (en) 2010-08-27
DE602007009378D1 (de) 2010-11-04
AU2007248341B2 (en) 2011-12-08
WO2007130780A3 (en) 2008-02-14
US20070259936A1 (en) 2007-11-08
ATE482201T1 (de) 2010-10-15
RS51473B (sr) 2011-04-30
PE20080065A1 (es) 2008-02-25
AU2007248341C1 (en) 2013-01-17
CA2651128C (en) 2014-09-02
DK2021330T3 (da) 2010-12-06
BRPI0709803A2 (pt) 2011-07-26
AU2007248341A1 (en) 2007-11-15
CN101511797A (zh) 2009-08-19
CY1111269T1 (el) 2015-08-05
SI2021330T1 (sl) 2011-01-31
PL2021330T3 (pl) 2011-03-31
KR101434883B1 (ko) 2014-08-27
CN101511797B (zh) 2013-01-02
JP5302884B2 (ja) 2013-10-02
NI200800290A (es) 2012-01-30
EP2021330B1 (en) 2010-09-22
NO341965B1 (no) 2018-03-05
IL194916A (en) 2013-01-31
EA019386B1 (ru) 2014-03-31
PT2021330E (pt) 2010-12-03
MY154595A (en) 2015-06-30
WO2007130780A2 (en) 2007-11-15
EA200870497A1 (ru) 2009-06-30
ZA200810234B (en) 2010-02-24
TW200808738A (en) 2008-02-16
AR060840A1 (es) 2008-07-16
KR20090008428A (ko) 2009-01-21
US20110190364A1 (en) 2011-08-04
HRP20100700T1 (hr) 2011-02-28
JP2009535414A (ja) 2009-10-01
HK1131971A1 (en) 2010-02-12
TWI419882B (zh) 2013-12-21
BRPI0709803B8 (pt) 2021-05-25
EP2021330A2 (en) 2009-02-11
UA94749C2 (en) 2011-06-10

Similar Documents

Publication Publication Date Title
UY30322A1 (es) Moduladores bencimidazólicos de vr1
CR10213A (es) Moduladores de la proteína quinasa aurora
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
EA201100037A1 (ru) Органические соединения
EA201170772A1 (ru) Органические соединения
SV2011003903A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa iv para el tratamiento o prevencion de diabetes
EA201401193A1 (ru) Триарильные соединения и композиции, их содержащие
EA201290183A1 (ru) Бензодиазепиновый ингибитор бромодомена
BR112015001613A2 (pt) compostos que são agentes de modulação de s1p e/ou agentes de modulação de atx
UY31065A1 (es) Heterociclos ciclicos
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
SV2008003045A (es) Aminotetrahidropiranos como inhibidores de dipertidil, peptidasa-iv para el tratamiento o prevencion de diabetes
EA200970156A1 (ru) Пиридизиноновые производные
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
CY1110900T1 (el) Χημικες ενωσεις
CY1108275T1 (el) Χημικες ενωσεις
GT200600327A (es) Ciclohexilaminoisoquinolona
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
HRP20090076A2 (hr) Antivirusni fosfinatni spojevi
UY30787A1 (es) "inhibidores benzoimidazolicos de trpv1"
CY1113102T1 (el) Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων
SV2010003650A (es) INHIBIDORES HETEROCICLICOS DE ESTEAROIL-CoA-DESATURASA
EA201171488A1 (ru) Lxr модуляторы
SG158091A1 (en) Imidazoazepinone compounds

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20190618